CD44 and glioma: Cohen et al. have shown thatlocal delivery of hyaluronan-coated LNPs containing siRNA for PLK1specifically target CD44 cells in a murine glioma model.213 The treatment induced internalization of theLNP, robust PLK1-silencing, and cell death of glioma cells prolongingsurvival of animals.